Develops insulin and obesity drugs for diabetes and weight loss.
Dec 2025Revenue DKK 309B/yrExpenses DKK 181B/yr
No trend
Figures by year
Is Novo Nordisk A S profitable?
Yes. In the 12 months to Dec 2025, revenue was DKK 309B and expenses DKK 181B.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | DKK 309B | DKK 181B | DKK 128B |
| Dec 2024 | DKK 290B | DKK 162B | DKK 128B |
| Dec 2023 | DKK 232B | DKK 130B | DKK 103B |
| Dec 2022 | DKK 177B | DKK 102B | DKK 74.8B |
| Dec 2021 | DKK 141B | DKK 82.2B | DKK 58.6B |
| Dec 2020 | DKK 127B | DKK 72.8B | DKK 54.1B |
| Dec 2019 | DKK 122B | DKK 69.5B | DKK 52.5B |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.